Absci (ABSI) Stock Price Target Increased on Positive Trial Data
Published on · Source: investing.com
AI Summary
Summarized by AI from the source belowH.C. Wainwright has raised its price target for Absci (ABSI) following the release of positive trial data. The new target reflects optimism about the company’s prospects based on the trial performance. While specific figures were not disclosed in the report, this adjustment indicates investor confidence in Absci's future. The price target change could influence investor behavior in the market, potentially affecting Absci's stock performance.
Informational only, not financial advice. Content is AI-generated and may contain errors. How this works.
Get the weekly market brief
One email every Monday: what moved, why, and what to watch. Free, unsubscribe anytime.
Get stories like this as they break
Our Telegram channel posts every market story the moment it is published. Free, and you can mute or leave anytime.
